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The murine gammaherpesvirus 68 (MHV-68) is an ideal model system for the study of interactions between gammaher-
pesviruses and their hosts. Intranasal infection of mice with MHV-68 results in replication of the virus in the lung epithelium
followed by latent infection of B cells. Resolution of productive MHV-68 infection depends on the adaptive immune system,
but little is known about the role of innate immune mechanisms and the early interaction between the host and the virus. In
this report, we have used mice that are deficient in components of the early defence system, the common type I interferon
(IFN) receptor (IFN R), the transcriptional activator IRF-1, and the inducible nitric oxide synthase, to investigate the
contribution of these mechanisms to control of MHV-68 infection. We show that while wild-type mice are highly resistant to
infection with MHV-68, mice unresponsive to type I IFNs (IFN-a/b R2/2 ) are highly susceptible to the virus. At high
multiplicities of infection (m.o.i.; 4 3 106 PFU), 80–90% of IFN-a/b R2/2 mice succumb to infection, and at low m.o.i. (4 3 103
PFU), 50% mortality rates occur. Both high and low doses of virus lead to 100- to 1000-fold higher lung virus titres in IFN-a/b
R2/2 mice than are found in wild-type mice and result in systemic dissemination of the virus. Latently infected cells are
detectable in the spleens of IFN-a/b R2/2 mice earlier than in wild-type mice, and the numbers of latently infected cells are
10-fold higher in the IFN-a/b R2/2 mice during the acute phase of infection. We find IRF-1 has a critical role in protection from
fatal disease, whereas inducible nitric oxide synthase does not appear to be important. The results indicate that innate


























The gammaherpesviruses are an important group of
athogens in both humans and animals. In vivo studies
n the human gammaherpesviruses, Epstein–Barr virus
EBV) and Kaposi’s sarcoma herpesvirus (HHV-8), are
everely limited and therefore murine gammaherpesvi-
us 68 (MHV-68; Blaskovic et al., 1980; Efstathiou et al.,
990) has been identified as an important model for
nvestigating host responses to virus infection.
There is good evidence that the adaptive immune
ystem plays a crucial role in MHV-68 infection. Intrana-
al infection with the virus results in acute replication in
he lungs followed by latent infection in B lymphocytes
Sunil-Chandra et al., 1992a,1992b). Clearance of the lung
nfection is initially dependent on CD81 T cells (Ethisham
t al., 1993), but evidence from studies in MHC class
I-deficient mice suggests that in the longer term, CD41
cells play a role in controlling the replication of virus
Cardin et al., 1996). CD41 T cells are also responsible
or the cell proliferation resulting in splenomegaly, the
ransient peak in the number of latently infected cells
hat occurs during the second week postinfection (p.i.),
1 To whom reprint requests should be addressed. Fax: 44-131-650-
u511. E-mail: B.M.Dutia@ed.ac.uk.
173nd the infectious mononucleosis-like syndrome that fol-
ows splenomegaly (Usherwood et al., 1996; Cardin et al.,
996; Tripp et al., 1997).
Innate immune mechanisms are crucial for the control
f virus infection before the recruitment of adaptive de-
ence systems. The type I interferons (IFNs; IFN-a and
FN-b) play a vital role in the initiation of innate immunity
hrough a variety of mechanisms, including the activation
f natural killer (NK) cell cytotoxicity, regulation of cyto-
ine and cytokine receptor expression, and early induc-
ion of the inducible nitric oxide synthase (iNOS) (re-
iewed in Biron, 1998; Diefenbach et al., 1998). They also
irectly inhibit the replication of many viruses (Vilcek and
en, 1996). Previous studies have shown that the type I
FNs and iNOS are important in the survival of mice
nfected with high doses of MHV-68 (Virgin et al., 1997;
ulkarni et al., 1997), but there is no published study on
he kinetics of infection in the absence of these innate
efences.
We studied MHV-68 infection in mice with a targeted
isruption in an essential chain of the type I IFN receptor
ene (IFN-a/b R2/2; Muller et al., 1994). We also investi-
ated the role of the iNOS gene (Wei et al., 1995) and the
ranscription factor IRF-1 (Matsuyama et al., 1993) during
HV-68 infection. The IRF-1 gene is important, but not
ssential, for the induction of type I IFNs and for the
pregulation of type I and type II IFN-inducible genes
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174 DUTIA ET AL.Miyamoto et al., 1988; Pine et al., 1990; Matsuyama et
l., 1993; Kimura et al., 1994). IRF-12/2 mice are deficient
n NK cell function (Duncan et al., 1996) and in the ability
o mount Th1 responses (Lohoff et al., 1997). We show
hat IFN-a/b R2/2 mice are highly susceptible to MHV-68
nfection. The virus replicates to high titres, is widely
isseminated, and causes death at doses that are sub-
ethal in wild-type mice. IFN-a/b R2/2 mice exhibit im-
aired clearance of the acute infection and altered kinet-
cs of latent infection. Mice lacking the IRF-1 gene be-
ave similarly to the IFN-a/b R2/2 mice. However, iNOS
s not essential for the control of MHV-68 infection.
RESULTS
nfection of IFN-a/b R2/2 mice with MHV-68
To investigate the role of the type I IFNs in MHV-68
nfection, groups of 10 wild-type 129Sv and 10 IFN-a/b
2/2 mice were infected with various doses of MHV-68.
igure 1 shows the results of a representative experi-
ent in which infection with 4 3 106 PFU of virus led to
30% mortality rate in wild-type mice and a 90% mortality
ate in the IFN-a/b R2/2 mice. When wild-type mice were
nfected with #4 3 105 PFU, all the mice survived the
nfection, whereas 80% of the IFN-a/b R2/2 died in re-
ponse to 4 3 105 PFU and 50% died in response to 4 3
03 PFU. The survival time of the IFN-a/b R2/2 mice was
ependent on the multiplicity of infection. The mean time
o death of 50% of the mice was 7–8 days at high doses
f virus, whereas at 4 3 103 PFU it was 13 days. In some
xperiments, we found IFN-a/b R2/2 mice infected with
ow doses of virus dying up to 3 weeks p.i. (data not
hown). Interestingly, no deaths occurred in the wild-type
ice until 11 days p.i. These data show that type I IFNs
re important in the control of MHV-68 infection. The
esults also suggest that type I IFNs may continue to play
role at times when adaptive immune mechanisms have
ecome activated.
nfectious virus replication in IFN-a/b R2/2 mice
The replication of MHV-68 in IFN-a/b R2/2 mice was
nvestigated by determining the titres of infectious virus
resent in the lungs and adrenal glands of wild-type and
FN-a/b R2/2 mice. Age- and sex-matched mice, four per
ime point, were infected with high (4 3 105 PFU/mouse)
r low (4 3 103 PFU/mouse) doses of virus. Figure 2
hows the lung virus titres obtained in a representative
xperiment. At both high and low doses of virus, the peak
itres of virus in the lungs of IFN-a/b R2/2 mice were 107
o 108 PFU/lung. This is 100- to 1000-fold higher than that
n wild-type mice. The peak lung titres of virus were
ndependent of the infectious dose that the mice re-
eived, although the peak titres occurred 2 days later at
ower infectious doses. In IFN-a/b R2/2 mice infected
3ith 4 3 10 PFU virus, infectious virus could be recov- ired from the lungs for up to 3 weeks p.i., indicating
mpaired clearance. When mice were infected with 4 3
05 PFU virus, no virus was recovered at day 12 or later.
owever, because 90% of mice infected with this dose
ie within 10 days, the mice sampled at day 12 or later
epresent the 10% that have survived the infection and
ecovered.
The adrenal gland is readily infected by MHV-68, and
e use this tissue as an indicator of systemic spread. In
FN-a/b R2/2 mice, infectious virus was readily detected
n the adrenal glands. Similar titres were found in mice
nfected with high and low doses (Fig. 3) and, as with the
ungs, there was a lag in the appearance of peak virus
itres in the mice infected with 4 3 103 PFU. All mice
FIG. 1. Survival rates of wild-type and IFN-a/b R2/2 mice infected
ntranasally with MHV-68. Groups of 10 mice were infected with various
oses of virus and monitored daily. Results are representative of two
xperiments. (a) 4 3 106 PFU/mouse. (b) 4 3 105 PFU/mouse. (c) 4 3103
















































175TYPE I IFNs IN MURINE GAMMAHERPESVIRUS 68 INFECTIONhis tissue by day 12 p.i. Similarly, the low-dose mice had
leared the adrenal gland infection by 12 days, although
irus could still be detected in the lungs of this group at
1 days p.i. No infectious virus could be detected in the
drenal glands of wild-type mice at any time after infec-
ion.
FIG. 2. Lung infectious virus titres in mice infected with MHV-68.
oints represent individual mice. (a) Mice infected with 4 3 103 PFU
irus. (b) Mice infected with 4 3 105 PFU virus. L, Wild-type 129Sv
ice. f, IFN-a/b R2/2 mice. The limit of detection was 10 PFU/lung.
FIG. 3. Replication of MHV-68 in the adrenal glands of IFN-a/b R2/2
ice. Points represent individual mice. l, Mice infected with 4 3 103
FU virus. M, Mice infected with 4 3 105 PFU virus. The limit of
etection was 10 PFU/adrenal. No infectious virus could be detected inshe adrenal glands of wild-type mice.atent virus infection in IFN-a/b R2/2 mice
We investigated the appearance of latently infected
ells in the spleens of wild-type and IFN-a/b R2/2 after
nfection with 4 3 103 PFU of virus. The lower multiplicity
as chosen because of the low survival rates of IFN-a/b
2/2 mice infected at higher doses. Figure 4 shows a
epresentative experiment in which latent virus could be
etected in the spleens of IFN-a/b R2/2 mice as early as
days p.i. In contrast, no latently infected cells were
etected in wild-type mice until 9 days p.i. The early
ppearance of latently infected cells in the spleen did not
orrelate with infectious virus in the lung where there
as no difference between wild-type and IFN-a/b R2/2
ice at early times (Fig. 2). The peak numbers of latently
nfected cells were 10-fold higher than those found in
ild-type mice and occurred 3–6 days earlier in IFN-a/b
2/2 mice. By 3 weeks p.i., however, similar numbers of
atently infected cells were found in both groups of mice.
nlike wild-type mice, infectious virus could be detected
n the spleens of IFN-a/b R2/2 mice (data not shown).
owever, the levels were no more than 10–100 PFU/
pleen, and this was taken into account when determin-
ng the latent virus titres shown in Fig. 4.
nfection in IRF-12/2 and iNOS2/2 mice
IRF-12/2 mice were highly susceptible to MHV-68 in-
ection and behaved similarly to the IFN-a/b R2/2 mice.
ll mice exhibited clinical symptoms, and 70% of mice
ied in response to 4 3 105 PFU (Fig. 5).
In contrast, iNOS-deficient mice were resistant to in-
ection with 4 3 105 PFU MHV-68. There was no sign of
linical disease and no deaths by day 17. These mice
leared the lung infection by day 7 and developed
plenomegaly and persistent infection in the spleen with
he same kinetics as wild-type 129 mice (data not
FIG. 4. Infective centers in the spleens of mice infected with 4 3 103
FU MHV-68. Points represent individual mice. L, Wild-type 129Sv

































176 DUTIA ET AL.istological analysis of infection in IFN-a/b R2/2 mice
Histological examination of haematoxylin and eosin-
tained sections of lung showed that infection of both
ild-type and IFN-a/b R2/2 mice with high or low
FIG. 5. Survival rates of wild-type and IRF-1 R2/2 mice infected
ntranasally with 4 3 105 PFU MHV-68. Ten wild-type and 10 IRF-1 R2/2
ice were infected. Results are representative of two experiments. L,
ild-type mice. f, IRF-1 R2/2 mice.
FIG. 6. Histochemical staining of tissues from wild-type and IFN-a/b R
ere stained with haematoxylin and eosin or with polyclonal rabbit ant
a) Wild-type lung, haematoxylin and eosin (380). (b) Wild-type lung, a
FN-a/b R2/2 anti-MHV-68 (3200). (e) Wild-type spleen, anti-MHV-68 (arr
oxes in a and c indicate areas enlarged in b and d.oses of MHV-68 resulted in a general pattern of
nterstitial pneumonia with perivascular cuffing. How-
ver, at both doses of virus IFN-a/b R2/2 mice showed
evere pathological changes including signs of focal
aemorrhage and patchy necrosis in the lungs (data
ot shown). Figure 6 shows haematoxylin and eosin-
tained sections of lung from wild-type (Fig. 6a) and
FN-a/b R2/2 (Fig. 6c) mice 8 days after infection with
3 105 PFU MHV-68 together with serial sections
tained with polyclonal antiserum to MHV-68 lytic cy-
le antigens (Figs. 6b and 6d). Considerable lympho-
ytic infiltration can be seen in the wild-type lung, but
nly limited numbers of virus-positive cells are
resent. In contrast, the IFN-a/b R2/2 lung shows ex-
ensive spread of viral antigen. Viral replication in
eripheral tissues was also examined by antibody
taining. In wild-type mice, an occasional cell contain-
ng replicating virus could be detected in the spleen
Fig. 6e). In IFN-a/b R2/2 mice, large numbers of pos-
tive cells were scattered throughout the red and white
ulp. Antigen-positive cells were also found in the liver
f IFN-a/b R2/2 mice (data not shown). These results
ce. Sections of lung and spleen 8 days after infection with 4 3 105 PFU
68. MHV-68 positive cells were stained brown with diaminobenzidine.
V-68 (3200). (c) IFN-a/b R2/2 lung, haematoxylin and eosin (380). (d)











































































































177TYPE I IFNs IN MURINE GAMMAHERPESVIRUS 68 INFECTIONllustrate the importance of the type I IFNs in the
ontrol of MHV-68 infection. Histological examination
f lung tissue from IRF-12/2-infected mice showed se-
ere pathological changes similar to those seen in
FN-a/b R2/2 mice (data not shown).
DISCUSSION
IFN-a/b R2/2 mice have been used to investigate the
ole of type I IFNs in a number of virus infections, includ-
ng the RNA viruses lymphocytic choriomenigitis virus,
esicular stomatitis virus (VSV), Semliki forest virus, and
heiler’s virus and the DNA virus vaccinia virus (Van den
roek et al., 1995). In all of these experiments, type I IFNs
ere shown to play a major role in the control of infec-
ion. Evidence for a role of type I IFNs in herpesvirus
nfections comes from studies on the administration
FNs (Rasmussen and Farley, 1975; Fish et al., 1983) and
rom work that demonstrates the importance of NK cells
n clearance of infection (reviewed in Biron, 1997). Stud-
es with EBV indicate that type I IFNs can downregulate
roliferative responses to EBV in vitro (Aman and von
abain, 1990), and evidence that the EBERs interfere
ith the function of IFN in vitro (Clarke et al., 1991)
uggests that type I IFN activity is important in EBV
nfection. The data presented here provide the first de-
ailed study of the consequences of a lack of type I IFN
ctivity in an acute gammaherpesvirus infection and in
he establishment of latent infection.
IFN-a/b R2/2 mice infected at high doses died quickly
n response to MHV-68 infection. At 6 days p.i., lung virus
itres were 100- to 1000-fold higher than those in the
ild-type mice. However, some mice survived the infec-
ion and by day 12 p.i. had cleared all virus from their
ungs. This is unlikely to be due to poor infection be-
ause 50% of mice infected with low doses had not
leared virus by this time. The kinetics of the infection in
ice infected at low doses differed from those in the
igh-dose mice. The low-dose mice had a longer mean
urvival time and higher survival rate even though the
ung titres were similar to those in mice infected at high
oses. Interestingly, infectious virus could be recovered
rom the lungs of these mice at 21 days p.i. It is likely that
he higher survival rate of the low-dose mice reflects the
ctivation of protective cytotoxic T lymphocyte and anti-
ody responses in the second week of infection. This
oes not, however, account for the slow clearance of the
irus from the lungs. Type I IFNs have long been known
o activate NK cells (Biron, 1997) and recently have been
hown to play a role in activation of memory T cells
Tough et al., 1996). The results presented here raise the
uestion as to whether they also have a role in the
ctivation of primary CD81 T cell responses similar to the
ctivation of NK cells. This is currently under investiga-
ion.
2/2Infectious virus assays indicated that in IFN-a/b R aice virus replication occurred in tissues other than the
ungs. Such replication was not detected in wild-type 129
ice by infectious virus assays, although occasional
irus-positive cells were detected by immunohistochem-
cal staining. Large numbers of positive cells were de-
ected by antibody staining in the IFN-a/b R2/2 mice.
ntibody staining does not distinguish between produc-
ive and abortive infections, but it is likely that in the
utant mice staining detects replicating virus. Replicat-
ng virus has been found in the adrenal glands of young
ALB/c mice (Sunil-Chandra et al., 1992a) and in mice
epleted of CD81 T cells (Ethisham et al., 1993). The
pread of virus from lungs to spleen requires B cells
Usherwood et al., 1996), and it is likely that dissemina-
ion of infection occurs via blood-borne B cell-associated
irus. In very young or CD81 T cell-depleted mice, virus
ay spread from B cells in the absence of a competent
mmune system. This may also be the case in IFN-a/b
2/2 mice. However, an alternative explanation may be
hat lack of type I IFN allows latently infected B cells to
eadily undergo a productive infection, resulting in pe-
ipheral spread of the virus.
Higher numbers of latently infected cells were found
4 days p.i. in the spleens of IFN-a/b R2/2 mice com-
ared with wild-type. It is interesting that latently infected
ells appeared in the spleens of IFN-a/b R2/2 mice
arlier than in wild-type mice even though virus titres in
he lung were identical until after day 6. Exactly how this
ight occur is unclear, but it is likely that type I IFNs have
role in preventing infection of B cells. Hence cells are
nfected at earlier time points and in greater numbers in
FN-a/b R2/2 mice. At later times, however, the IFN-a/b
2/2 mice have similar numbers of latently infected cells
o those found in wild-type mice. This parallels the situ-
tion in IFN-g R2/2 mice, which have peak latency loads
00- to 1000-fold higher than those in wild-type mice but
stablish similar latency loads in the longer term (Dutia
t al., 1997). Similarly, the long-term latency levels in
D41 T cell-depleted mice are the same as in unde-
leted mice, although these mice behave differently dur-
ng the initial phase of infection (Nash et al., 1996). The
echanism controlling the number of latently infected
ells is not well understood, but CD81 T cells clearly play
role (Cardin et al., 1996). It is likely that as the adaptive
mmune response develops, it is able to operate the
ame latency control mechanism in immunocompro-
ised mice, such as the IFN-a/b R2/2 mice and the IFN-g
2/2 mice, as in intact mice. These mechanisms are
ntriguing and require further study.
IRF-12/2 mice, unlike IFN-a/b R2/2 mice, are resistant
o infection with VSV, indicating that induction of a type I
FN-dependent antiviral state against VSV is indepen-
ent of IRF-1 (Matsuyama et al., 1993; Reis et al., 1994;
uller et al., 1994). Clearly, this is not the case for


























































































178 DUTIA ET AL.NA-activated protein kinase or 2-5A synthetase can
ccur in the absence of IRF-1 (Kimura et al., 1994). Al-
hough these activities may be important in MHV-68
nfection, the requirement for IRF-1 indicates that IRF-1-
ependent activities, such as induction of NK cell activity,
re an important component of the type I IFN-dependent
ntiviral state in MHV-68 infection.
Our results showing that a lack of iNOS has no effect
n the replication of MHV-68 are in direct contrast to
hose of Kulkarni et al. (1997). This is not readily ex-
lained, but the mice used in this study were derived
ndependently from those used by Kulkarni and cowork-
rs, and the results may be attributable to the different
ackgrounds of the mice.
Type I IFN receptors are present on all cell types,
ncluding epithelial cells and lymphocytes (Aguet and
ogensen, 1983). The current experiments cannot differ-
ntiate between direct antiviral effects that occur in lung
pithelial cells and indirect mechanisms such as activa-
ion of NK cytotoxicity. Experiments aimed at identifying
he cell types involved in the protective effect are under
ay.
The type I and type II IFNs display similar antiviral
ctivities and share signaling pathway components
Bach et al., 1997). However, a comparison of MHV-68
nfection in type I and type II IFN receptor-deficient mice
ndicates very different roles for the two types of IFN in
HV-68 infection. The lack of the IFN-g receptor (IFN-g
2/2) has no effect on the clearance of MHV-68 from the
ungs or, in our experience, on the survival of the mice.
HV-68-infected IFN-g R2/2 mice, however, develop se-
ere pathological and virological changes in the spleens
Dutia et al., 1997). As shown here, IFN-a/b R2/2 mice are
ighly susceptible to MHV-68 infection, but there is no
vidence of splenic atrophy and splenomegaly occurs as
n wild-type mice. Although the mechanism of splenic
trophy is presently unknown, it does not appear to
nvolve common pathways with those involved in type I
FN activity.
Type I IFNs have been shown to induce bystander T
ell proliferation of CD81 T cells with a memory pheno-
ype (Tough et al., 1996) and thus have a potential role in
he generation of immunological memory. We are cur-
ently investigating the frequency of T cell memory in
ild-type and IFN-a/b R2/2 mice and monitoring the
requency of spontaneous reactivation in these mice as
correlate of a diminishing immunological control.
MATERIALS AND METHODS
irus
MHV-68 was originally obtained from Prof. Blaskovic
Blaskovic et al., 1980). Working stocks of MHV-68 were
repared by infection of BHK-21 cells with MHV-68 clone
2.4 (Efstathiou et al., 1990) at low multiplicity (0.1 PFU/ Aell) as previously described (Sunil-Chandra et al.,
992a).
ice
Inbred wild-type 129/Sv and IFN-a/b R2/2 129/Sv mice
Muller et al., 1994) were obtained from B & K Universal
imited (Hull, U.K.) and maintained as a closed colony.
RF-12/2 mice (Matsuyama et al., 1993) were obtained
rom the Department of Medical Microbiology, University
f Edinburgh. iNOS2/2 mice were a generous gift from
rof. F. Y. Liew, University of Glasgow. Age- and sex-
atched mice were infected under halothane anaesthe-
ia at 6–12 weeks of age.
irus assays
Virus stocks were assayed on BHK-21 cell monolayers
Sunil-Chandra et al., 1992a). To determine virus titres in
nfected mice, various tissues were frozen at 270°C,
hawed and homogenised, and then refrozen at 270°C.
fter thawing, the homogenates were centrifuged to re-
ove particulate matter and titred on BHK-21 cell mono-
ayers as described above for virus stocks. Latent virus
as detected by an infective center assay (Sunil-Chan-
ra et al., 1992a). Briefly, spleen cell suspensions were
repared by teasing cells out of the capsule, red blood
ells were lysed by brief resuspension in water, and the
ymphocytes were cocultivated with BHK-21 cells for 5
ays. Cell monolayers were fixed and stained, and the
umbers of splenocytes giving rise to plaques counted.
o detect infectious virus in splenocytes, these cells
ere frozen at 270°C, thawed, clarified by centrifuga-
ion, and assayed on BHK-21 cell monolayers.
istological analysis
Tissues were fixed in 10% formol saline and processed
o 5-mm paraffin wax-embedded sections. MHV-68 lytic
ycle antigens were detected with polyclonal rabbit an-
iserum raised against infected cell lysate. Sections were
locked overnight with normal goat serum and then
ncubated for 2 h with polyclonal serum followed by
iotinylated anti-rabbit Ig, streptavidin peroxidase
Boehringer Mannheim UK), and diaminobenzidine
Sigma). Serial sections were stained with haematoxylin
nd eosin and examined by light microscopy.
ACKNOWLEDGMENTS
This work was funded by the Medical Research Council (UK). The
uthors are grateful to Dr. C. J. Clarke for advice on pathology and Prof.
. J. Harrison for useful discussion. N. McIntyre provided excellent
echnique assistance.
REFERENCES
guet, M. and Mogensen, K. E. (1983). “Interferon 5” (I. Gresser, Ed.) pp.
































179TYPE I IFNs IN MURINE GAMMAHERPESVIRUS 68 INFECTIONization associated gene segment interferes specifically with the
IFN-induced anti-proliferative response in human B-lymphoid cell
lines. EMBO J. 9, 147–152.
ach, E. A., Aguet, M., and Schreiber, R. D. (1997). The IFN-g Receptor:
a paradigm for cytokine receptor signaling. Annu. Rev. Immunol. 15,
563–591.
iron, C. A. (1997). Natural killer cell responses during viral infections.
Curr. Opin. Immunol. 9, 24–34.
iron, C. A. (1998). Role of early cytokines, including alpha and beta
interferons (IFN-a/b) in innate and adaptive immune responses to
viral infections. Semin. Immunol. 10, 383–390.
laskovic, D., Stancekova, J., Svobodova, J., and Mistrikova, J. (1980).
Isolation of five strains of herpesviruses from two species of freeliv-
ing small rodents. Acta Virol. 24, 468.
ardin, R. D., Brooks, J. W., Sarawar, S. R., and Doherty, P. C. (1996).
Progressive loss of CD81 T cell-mediated control of a g-herpesvirus
in the absence of CD41 T cells. J. Exp. Med. 184, 863–871.
larke, P. A., Schwemmle, M., Schickinger, J., Hilse, K., and Clemens,
M. J. (1991). Binding of Epstein-Barr virus small RNA EBER-1 to the
double stranded RNA-activated protein kinase DAI. Nucleic Acids
Res. 19, 243–248.
iefenbach, A., Schindler, H., Donhauser, N., Lorenz, E., Laskay, T.,
MacMicking, J., Rollinghoff, M., Gresser, I., and Bogdan, C. (1998).
Type I interferon (IFNa/b) and type 2 nitric oxide synthase regulate
the innate immune response to a protozoan parasite. Immunity 8,
77–87.
uncan, G. S., Mittrucker, H., Kagi, D., Matsuyama, T., and Mak, T. W.
(1996). The transcription factor interferon regulatory factor-1 is es-
sential for natural killer cell function in vivo. J. Exp. Med. 184,
2043–2048.
utia, B. M., Clarke, C. J., Allen, D. A., and Nash, A. A. (1997). Patho-
logical changes in the spleens of gamma interferon receptor-defi-
cient mice infected with murine gammaherpesvirus: A role for CD8 T
cells. J. Virol. 71, 4278–4283.
fstathiou, S., Ho, Y. M., Hall, S., Styles, C. J., Scott, S. D., and Gompels,
U. A. (1990). Murine herpesvirus 68 is genetically related to the
gammaherpesviruses Epstein-Barr and herpesvirus Saimiri. J. Gen.
Virol. 71, 1365–1372.
thisham, S., Sunil-Chandra, N. P., and Nash, A. A. (1993). Pathogenesis
of murine gammaherpesvirus infection in mice deficient in CD4 and
CD8 T cells. J. Virol. 67, 5247–5252.
ish, E. N., Banerjee, K., and Stebbing, N. (1983). Antiviral activities of
cloned human leukocyte interferons against herpes simplex type 2
infections of mice. J. Gen. Virol. 64, 2317–2321.
imura, T., Nakayama, K., Penninger, J., Kitagawa, M., Harada, H.,
Matsuyama, T., Tanaka, N., Kamijo, R., Vilcek, J., Mak, T. W., and
Taniguchi, T. (1994). Involvement of the IRF-1 transcription factor in
antiviral responses to interferons. Science 264, 1921–1924.
ulkarni, A. B., Holmes, K. L., Fredrickson, T. N., Hartley, J. W., and
Morse, H. C. I. (1997). Characteristics of a murine gammaherpesvirus
infection immunocompromised mice. In Vivo 11, 281–292.
ohoff, M., Ferrick, D., Mittrucker, H., Duncan, G. S., Bischoff, S., Rol-
linghoff, M., and Mak, T. W. (1997). Interferon regulatory factor-1 is
required for a T helper 1 immune response in vivo. Immunity 6,
681–689.
atsuyama, T., Kimura, T., Kitagawa, M., Pfeffer, K., Kawakami, T.,
Watanabe, N., Kundig, T. M., Amakawa, R., Kishihara, K., Wakeham,
A., Potter, J., Furlonger, C. L., Nerendran, A., Suzuki, H., Ohashi, P. S.,Paige, C. J., Taniguchi, T., and Mak, T. W. (1993). Targeted disruption
of IRF-1 or IRF-2 results in abnormal type I IFN gene induction and
aberrant lymphocyte development. Cell 75, 83–97.
iyamoto, M., Fujita, T., Kimura, Y., Maruyama, m., Harada, H., Sudo, Y.,
Miyata, T., and Taniguchi, T. (1988). Regulated expression of a gene
encoding a nuclear factor, IRF-1, that specifically binds to IFN-b gene
regulatory elements. Cell 75, 83–87.
uller, U., Steinhoff, U., Reis, L. F. L., Hemmi, S., Pavlovic, J., Zinkerna-
gel, R. M., and Aguet, M. (1994). Functional role of type I and type II
interferons in antiviral defense. Science 264, 1918–1921.
ash, A. A., Usherwood, E. J., and Stewart, J. P. (1996). Immunological
features of murine gammaherpesvirus infection. Semin. Virol. 7, 125–
130.
ine, R., Levy, D. E., Reich, N., and Darnell, J. E. J. (1990). Purification and
cloning of interferon-stimulated gene factor 2 (ISGF2): ISGF2 (IRF-1)
can bind to the promoters of both beta interferon and interferon-
stimulated genes but is not a primary transcriptional activator of
either. Mol. Cell. Biol. 10, 2448–2457.
asmussen, L., and Farley, L. B. (1975). Inhibition of herpesvirus homi-
nis replication by human interferon. Infect. Immunol. 12, 104–108.
eis, L. F. L., Harada, H., Wolchok, J. D., Taniguchi, T., and Vilcek, J.
(1992). Critical role of a common transcription factor, IRF-1, in the
regulation of IFN-b and IFN-inducible genes. EMBO J. 11, 185–193.
unil-Chandra, N. P., Efstathiou, S., Arno, J., and Nash, A. A. (1992a).
Virological and pathological features of mice infected with murine
gammaherpesvirus 68. J. Gen. Virol 73, 2347–2356.
unil-Chandra, N. P., Efstathiou, S., and Nash, A. A. (1992b). Murine
gammaherpesvirus 68 establishes a latent infection in mouse B
lymphocytes in vivo. J. Gen. Virol. 73, 3275–3279.
ough, D. E., Borrow, P., and Sprent, J. (1996). Induction of bystander
T-cell proliferation by viruses and type I interferon in vivo. Science
272, 1947–1950.
ripp, R. A., Hamilton-Easton, A. M., Cardin, R. D., Nguyen, P., Bemn,
F. G., Woodlane, D. L., Doherty, P. C., and Blackman, M. A. (1997).
Pathogenesis of an infectious mononucleosis-like disease induced
by a murine g-herpesvirus: Role for a viral superantigen? J. Exp. Med.
185, 1641–1650.
sherwood, E. J., Ross, A. J., Allen, D. J., and Nash, A. A. (1996a). Murine
gammaherpesvirus-induced splenomegaly: A critical role for CD4 T
cells. J. Gen. Virol. 77, 627–630.
sherwood, E. J., Stewart, J. P., Robertson, K., Allen, D. J., and Nash,
A. A. (1996b). Absence of splenic latency in murine gammaherpes-
virus 68-infected B cell-deficient mice. J. Gen. Virol. 77, 2819–2825.
an den Broek, M. F., Muller, U., Huang, S., Zinkernagel, R. M., and
Aguet, M. (1995). Immune defence in mice lacking type I and/or type
II interferon receptor. Immunol. Rev. 148, 5–18.
ilcek, J., and Sen, G. C. (1996). Interferons and other cytokines. In
“Fields Virology,” 3rd ed. (B. N. Fields, D. M. Knipe, P. M. Howley, et
al., Eds.) pp. 375–399. Lippincott-Raven, Philadelphia.
eck, K. E., Dal Canto, A. J., Gould, J. D., O’Guin, A. K., Roth, K. A., Saffitz,
J. E., Speck, S. H., and Virgin, H. W. I. (1997). Murine g-herpesvirus 68
causes severe large-vessel arteritis in mice lacking interferon-g
responsiveness: A new model for virus-induced vascular disease.
Nat. Med. 3, 1346–1353.
ei, X., Charles, I. G., Smith, A., Ure, J., Feng, G., Huang, F., Xu, D.,
Muller, W., Moncada, S., and Liew, F. Y. (1995). Altered immune
responses in mice lacking inducible nitric oxide synthase. Nature
375, 408–411.
